ATAI · Categories · Form 4

ATAI - SEC Form 4 insider transactions

AtaiBeckley Inc. (ATAI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ATAI

• 1d
  SEC Form 4 filed by Director Angermayer Christian

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Braunstein Scott

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Fischer Laurent

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Kalali Amir H

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Hoffman John Francis

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Smiley Andrea Heslin

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Johnson Sabrina Martucci

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 1d
  SEC Form 4 filed by Director Hershberg Robert

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 48d
  SEC Form 4 filed by Craig Kevin James

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 195d
  SEC Form 4 filed by Director Feilding-Mellen Cosmo

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 215d
  SEC Form 4 filed by Director Hershberg Robert

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 215d
  Director Feilding-Mellen Cosmo was granted 7,702,990 shares (SEC Form 4)

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 215d
  SEC Form 4 filed by Director Braunstein Scott

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 249d
  SEC Form 4 filed by Officer Barrett Christopher Ryan Cave

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 250d
  Large owner Apeiron Investment Group Ltd. converted options into 2,367,200 shares (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 298d
  SEC Form 4 filed by Officer Rao Srinivas

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Hoffman John Francis

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Johnson Sabrina Martucci

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Kalali Amir H

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Smiley Andrea Heslin

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Braunstein Scott

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Fischer Laurent

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 347d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 370d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 442d
  Chief Scientific Officer Short Glenn Frank sold $17,767 worth of shares (13,161 units at $1.35), decreasing direct ownership by 24% to 42,333 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 442d
  Chief Business Officer Kirpekar Sahil sold $65,560 worth of shares (48,563 units at $1.35), decreasing direct ownership by 30% to 115,636 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 442d
  Chief Financial Officer Johnson Anne Nagengast sold $45,286 worth of shares (33,545 units at $1.35), decreasing direct ownership by 19% to 140,045 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 442d
  Officer Rao Srinivas sold $101,814 worth of shares (75,418 units at $1.35), decreasing direct ownership by 26% to 212,942 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 442d
  Chief Medical Officer Craig Kevin James sold $15,610 worth of shares (11,563 units at $1.35), decreasing direct ownership by 58% to 8,437 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 447d
  Officer Rao Srinivas converted options into 175,000 shares, increasing direct ownership by 154% to 288,360 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 447d
  Chief Scientific Officer Short Glenn Frank converted options into 32,500 shares, increasing direct ownership by 141% to 55,494 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 447d
  Chief Medical Officer Craig Kevin James converted options into 20,000 shares (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 447d
  Chief Business Officer Kirpekar Sahil converted options into 100,000 shares, increasing direct ownership by 156% to 164,199 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 447d
  Chief Financial Officer Johnson Anne Nagengast converted options into 100,000 shares, increasing direct ownership by 136% to 173,590 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 460d
  SEC Form 4 filed by Chief Scientific Officer Short Glenn Frank

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 460d
  SEC Form 4 filed by Chief Medical Officer Craig Kevin James

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 461d
  SEC Form 4 filed by Chief Financial Officer Johnson Anne Nagengast

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 515d
  SEC Form 4 filed by Officer Rao Srinivas

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 522d
  SEC Form 4 filed by Chief Operating Officer Kochendoerfer Gerd

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 613d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 613d
  SEC Form 4 filed by Chief Financial Officer Johnson Anne Nagengast

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 613d
  SEC Form 4 filed by Officer Brand Florian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 613d
  SEC Form 4 filed by Officer Rao Srinivas

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 620d
  Large owner Atai Life Sciences N.V. sold $16,093,000 worth of Ordinary Shares (2,660,000 units at $6.05) (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Reporting)
• 725d
  SEC Form 4 filed by Director Auerbach Michael

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 725d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 725d
  SEC Form 4 filed by Director Braunstein Scott

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 725d
  SEC Form 4 filed by Director Kalali Amir H

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 725d
  SEC Form 4 filed by Director Fischer Laurent

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 725d
  SEC Form 4 filed by Director Smiley Andrea Heslin

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 725d
  SEC Form 4 filed by Director Johnson Sabrina Martucci

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 750d
  Brand Florian sold $290,502 worth of shares (151,303 units at $1.92), decreasing direct ownership by 32% to 328,697 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 767d
  SEC Form 4 filed by Atai Life Sciences N.V.

  4 - ATAI Life Sciences N.V. (0001840904) (Reporting)
• 783d
  SEC Form 4 filed by Apeiron Investment Group Ltd.

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 796d
  Rao Srinivas sold $114,034 worth of shares (61,640 units at $1.85), decreasing direct ownership by 35% to 113,360 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 796d
  Johnson Anne Nagengast sold $50,708 worth of shares (27,410 units at $1.85), decreasing direct ownership by 27% to 73,590 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 796d
  Kirpekar Sahil sold $66,232 worth of shares (35,801 units at $1.85), decreasing direct ownership by 36% to 64,199 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 816d
  Johnson Anne Nagengast converted options into 100,000 shares, increasing direct ownership by 10,000% to 101,000 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 816d
  Kirpekar Sahil converted options into 100,000 shares (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 816d
  Rao Srinivas converted options into 175,000 shares (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)

Other ATAI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends